Fundz

Manifold Biotechnologies, Inc. reported raising $40 Million in an initial SEC Form D filing, from an offering of $40 Million

PRIVATEJun 13, 2022

Amount Raised

$40 Million

$40 Million sold, per SEC Form D (first sale Jun 13, 2022)

Round Type

Venture

AllstonBiotechnology

Quick answer

Manifold Bio raised $40 Million in a funding round, dated June 13, 2022. Manifold Bio is based in Allston, Massachusetts, United States.

How much did Manifold Bio raise?
Manifold Bio raised $40 Million in a funding round on June 13, 2022.
What does Manifold Bio do?
Manifold Bio is a platform therapeutics company building the first AI-guided direct-to-vivo discovery platform to accelerate the development of tissue-targeted medicines.
Where is Manifold Bio based and how big is it?
Manifold Bio is based in Allston, Massachusetts, United States.
Who are the decision-makers at Manifold Bio?
Fundz holds 1 contact at Manifold Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Manifold Bio that raised within 45 days of this round, from Fundz verified event records.

  • Animol raised $34M (Series B) on July 28, 2022.
  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
  • SEngine Precision Medicine, Inc. raised an undisclosed amount (Series A) on July 28, 2022.
  • Suvera raised $6.5M (Funding Round) on July 28, 2022.
  • Core Biogenesis raised $11M (Funding Round) on July 28, 2022.

Who to call at Manifold Bio, and when

A new round usually means Manifold Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Manifold Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Manifold Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Manifold Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Manifold Bio

Location

Allston, Massachusetts, United States

About

Manifold Bio is a platform therapeutics company building the first AI-guided direct-to-vivo discovery platform to accelerate the development of tissue-targeted medicines. By testing thousands of molecules simultaneously in vivo, Manifold uncovers delivery strategies that unlock new therapeutic possibilities across neurodegenerative, metabolic, and other major diseases. Its mDesign engine integrates AI-guided protein design with multiplexed in vivo data, creating a virtuous cycle of design and translation. In addition to developing its internal pipeline of novel medicines, Manifold collaborates with leading pharmaceutical partners worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Manifold Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts7 people are listed at Manifold Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Manifold Bio's next move

See what Strategic adds

Manifold Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.